{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-005019","form_type":"8-K","ticker":"RGNX","cik":"0001590877","company_name":"REGENXBIO Inc.","filed_at":"2023-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.735058+00:00","generated_at":"2026-06-20T17:05:34.803665+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"REGENXBIO promotes Curran Simpson to COO, Shiva Fritsch to Chief Communications Officer","bullets":["Curran Simpson appointed COO effective Jan 9, 2023; previously SVP, Chief Technology and Operations Officer since 2015.","Shiva Fritsch elevated to Chief Communications Officer while retaining Chief People Officer role; joined REGENXBIO in 2017.","Promotions follow opening of Manufacturing Innovation Center and progress toward '5 x '25' strategy for five AAV therapeutics.","Simpson will oversee manufacturing, quality, regulatory, preclinical development, and corporate strategy.","Fritsch will oversee internal/external communications and human resources."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-005019","json":"https://secwatch.observer/filing/0001193125-23-005019.json","markdown":"https://secwatch.observer/filing/0001193125-23-005019.md","text":"https://secwatch.observer/filing/0001193125-23-005019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590877/000119312523005019/0001193125-23-005019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590877/000119312523005019/d120677d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T17:05:34.803665+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4155d18c32","claim":"Curran M. Simpson was named as Chief Operating Officer at REGENXBIO Inc..","evidence_excerpt":"On January 9, 2023, REGENXBIO Inc. (the “Company”) announced that Curran M. Simpson has been named Chief Operating Officer, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1590877/000119312523005019/0001193125-23-005019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"named"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}